China’s SFDA Denies Illegal Exports Of Performance-Enhancing Drugs
This article was originally published in PharmAsia News
Chinese regulators deny U.S. reports that China's bulk-drugs suppliers were illegally exporting performance-enhancing drugs to the United States. Wu Zhen, deputy head of the State FDA, said most of such shipments were clearly labeled and had company contracts, export licenses and "warrants from the importing countries." Wu said it was the responsibility of importing countries to police the illegal use of any legally imported drugs. China is emphasizing its own crackdown on use of steroids and other performance-enhancing drugs in advance of the summer Olympics. (Click here for more
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.